The Global Nerve Repair and Regeneration Market is Estimated to reach $9.4 Billion by 2028, at a CAGR of 6.4%

Nerve Repair and Regeneration Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Nerve Repair and Regeneration Market size is expected to reach $9.4 billion by 2028, rising at a market growth of 6.4% CAGR during the forecast period.

The Neuromodulation Surgery segment acquired maximum revenue share in the Global Nerve Repair and Regeneration Market by Surgery in 2021, thereby, achieving a market value of $4.69 billion by 2028. It is due to the fact that neuromodulation is a pain-relieving technique that is reversible. Neurosurgeons implant a gadget and utilise it to change the activity of specific nervous system pathways. Additionally, neuromodulation device can deliver either modest amounts of medication or a mild electrical current in one of two ways.

The Biomaterials market is showcasing a CAGR of 5.8% during (2022 - 2028). It is owing to the expansion in target population base and rise in awareness among patients. In addition, the prevalence of advanced healthcare technologies in the healthcare sector would further escalate the growth of the segment during the forecast period.

The North America market dominated the Global Nerve Repair and Regeneration Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $3.96 billion by 2028. The Asia Pacific market is estimated to witness a CAGR of 7.1% during (2022 - 2028). Additionally, The Europe market would experience a CAGR of 6.2% during (2022 - 2028).

Full Report: https://www.kbvresearch.com/nerve-repair-and-regeneration-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, Boston Scientific Corporation, Integra Lifesciences Corporation, Medtronic PLC, Axogen, Inc., Stryker Corporation, Checkpoint Surgical, Inc., Polyganics BV, Synovis Micro Companies Alliance, Inc. (Baxter International, Inc.), and OrthoMed, Inc.

Global Nerve Repair and Regeneration Market Segmentation

By Surgery

• Neuromodulation Surgery
• Direct Neuropathy
• Nerve Grafting
• Stem Cell Therapy

By Product

• Neuromodulation Surgery Devices
• Biomaterials

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Abbott Laboratories
• Boston Scientific Corporation
• Integra Lifesciences Corporation
• Medtronic PLC
• Axogen, Inc.
• Stryker Corporation
• Checkpoint Surgical, Inc.
• Polyganics BV
• Synovis Micro Companies Alliance, Inc. (Baxter International, Inc.)
• OrthoMed, Inc.

Related Reports:

North America Nerve Repair and Regeneration Market Size, 2028

• May-2022
• 76 Pages

LAMEA Nerve Repair and Regeneration Market Size, 2022-2028

• May-2022
• 82 Pages

Europe Nerve Repair and Regeneration Market Size, 2022-2028

• May-2022
• 83 Pages

Asia Pacific Nerve Repair and Regeneration Market Size, 2028

• May-2022
• 82 Pages